Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001815776-25-000003
Filing Date
2025-01-13
Accepted
2025-01-13 17:20:45
Documents
4
Period of Report
2025-01-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1736806836.html 4  
1 FORM 4 wk-form4_1736806836.xml 4 4427
2 EX-24 schimmelpenninkpoa.htm EX-24 5030
3 schimmelpenninkpoa001.jpg GRAPHIC 258983
4 schimmelpenninkpoa002.jpg GRAPHIC 47979
  Complete submission text file 0001815776-25-000003.txt   434049
Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Schimmelpennink Evert B. (Reporting) CIK: 0001713795 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 25527102

Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)